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Recently, a proliferation of athletic supplements has been marketed touting boron as an ergogenic aid capable of increasing testosterone. The effect
of boron supplementation was investigated in male bodybuilders. Ten male bodybuilders (aged 20 to 26) were given a 2.5-mg boron supplement,
while nine male bodybuilders (aged 21 to 27) were given a placebo for 7 weeks. Plasma total and free testosterone, plasma boron, lean body mass,
and strength measurements were determined on day 1 and day 49 of the study. A microwave digestion procedure followed by inductively coupled
argon plasma spectroscopy was used for boron determination. Twelve subjects had boron values at or above the detection limit with median value
of 25 ng/ml (16 ng/ml lower quartile and 33 ng/ml upper quartile). Of the ten subjects receiving boron supplements, six had an increase in their
plasma boron. Analysis of variance indicated no significant effect of boron supplementation on any of the other dependent variables. Both groups
demonstrated significant increases in total testosterone (p<0.01), lean body mass (p<0.01), and one repetition maximum (RM) squat (p<0.001)
and one RM bench press (p<0.01). The findings suggest that 7 weeks of bodybuilding can increase total testosterone, lean body mass, and
strength in lesser-trained bodybuilders, but boron supplementation affects these variables not at all. - Environ Health Perspect 102(Suppl 7):
73-77 (1994)
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Introduction
Boron content in almost all human tissue
and body fluids is poorly documented.
Early investigations using colorimetry suf-
fered from contamination and other
methodologic problems and high values
were reported. Forbes et al. (1) and
Johnstone et al. (2) dry-ashed blood sam-
ples, then analyzed for boron colorimetri-
cally and reported 0.141 pg/ml and 0.4
pg/ml, respectively. Hill et al. (3) used a
wet-tissue digestion prior to analysis for
boron and found 0.12 pg/ml blood.
Then in 1963, Imbus et al. (4) pub-
lished blood boron values for the largest
sample (n = 147) found in the literature
to date. They dry-ashed samples and fol-
lowed with spectrographic analysis and
reported a median value of 90 ng/g and
mean of 114 ng/g with a range 39 to 365
ng/g (Table 1).
More recent studies using neutron acti-
vation with mass spectrometer, wet-diges-
tion with inductively coupled plasma-mass
spectrometry (ICP-MS), and wet-digestion
with inductively coupled plasma emission
spectrometer (ICP) have all reported lower
values. Ward (5), using prompt gamma
neutron activation, reported whole blood
boron range of 0.14 to 0.74 pg/ml dry
weight or approximately 28 to 148 ng/g.
Also in 1987, Clarke et al. (6) reported
values for whole blood analyzed by a mass-
spectrometric assay of'helium produced by
thermal neutron reaction with '0B. They
found a mean boron concentration of
30.8 ng/g with a range of 15.3 to 79.5
ng/g. Abou-Shakra et al. (7) reported
whole blood boron on a population of 50
analyzed by wet digestion prior to ICP-
MS. They found a median boron value of
56.7 ng/ml, lower quartile 49.2 and upper
quartile 72.0, with a range from 8.4 to
170.4 (Table 1).
Our interest in boron was stimulated in
1987 when Nielsen et al. (8) reported its
effects on mineral metabolism in 12 post-
menopausal women. Boron supplementa-
tion of3 mg/day was found to reduce uri-
nary calcium in a low-magnesium diet, and
to significantly increase serum estrogen and
testosterone.
Athletes involved in weight training for
increased strength or muscular size have
long sought to enhance their natural testos-
terone levels. The use of exogenous testos-
terone, or anabolic steroids, has been the
means ofchoice; however, the dangers and
side effects of these steroids are well docu-
mented (9), and the felonious nature of
their possession has prompted many ath-
letes to seek safer and more "natural"
means of enhancing their testosterone lev-
els. Recently, a proliferation ofathletic sup-
plements has been marketed, which tout
boron as an ergogenic aid capable of
increasing testosterone. The supposed effi-
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Table 1. Blood boron.
Imbus (4) Clarke (6) Abou-Shakra (7)
ng/gm ng/gm ng/ml
Median 98.5 NR 56.7
Lowerquartile NR NR 49.2
Upperquartile NR NR 72.0
Minimum 39.0 16.2 8.4
Maximum 365.0 79.5 107.4
Mean 114 30.8 NR
n 147 13 50
NR, not reported.
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cacy ofboron as an ergogenic aid is based
exclusively on the increased testosterone
values found in Nielsen's study (8) on
postmenopausal women.
Manufacturers of athletic supplements
often market products as anabolic or
ergogenic aids based on incomplete scien-
tific investigation. The effect of boron
supplementation demonstrated in a small
population of postmenopausal women
simply cannot be extrapolated to a popu-
lation of young athletes. Therefore, we
conducted a study to examine the effect of
a commercially-produced boron supple-
ment in healthy, male weightlifters on
plasma free and total testosterone, plasma
boron, lean body mass (LBM), and
strength values (10).
Methods
Subjec andTinng
Nineteen male weightlifters volunteered to
participate in this study. All the subjects
had been weight training for their own
conditioning purposes at least 1 year prior
to the study. Each subject outlined his
training regimen in a prestudy question-
naire and was instructed not to change his
existing regimen for the study. The subjects
weight trained 4 days a week throughout
the 7 weeks of this study using their own
bodybuilding protocols. No subject had
used anabolic steroids within a 6-month
period prior to the start ofthe experiment.
Subjects were randomly placed in a dou-
ble-blind fashion into one of two groups.
The experimental (boron) group (n = 10)
received a commercial boron supplement
and the control group (n = 9) a placebo
(milk protein). Both groups were given a
total of 49 tablets and instructed to take
one tablet per day. Compliance for both
groups was monitored through supplement
counts at the end ofthe study period.
All boron and placebo tablets were from
the same manufactured lots. Both were
analyzed for boron content.
Experimental Procedures
A 3-day dietary record was collected over
the first 3 days and last 3 days ofthe study
to assess nutritional intake of the subjects.
Diets were analyzed for nutrient composi-
tion utilizing the Nutritionist III
food/nutrient data base. Subjects were
instructed to continue their normal dietary
habits but were told to refrain from taking
any vitamin-mineral supplements or ath-
letic supplements 3 weeks prior to initia-
tion ofthe study.
Initially and following the supplementa-
tion period, subjects were weighed hydro-
statically for determination of lean body
mass. Blood was drawn on days 1 and 49
between 0830 and 0930 from the antecu-
bital vein for determination of plasma
boron and testosterone. Blood was drawn
on day 49 within 15 min ofthe time blood
was drawn on day 1. Venous blood was
collected into nonborosilicate vacutainers
with EDTA tubes for plasma analysis of
free and total testosterone. Blood was col-
lected into sodium-heparinized tubes for
blood boron analysis. All blood was cen-
trifuged at 3500g for 15 min. Plasma was
pipetted into acid-washed (HNO3)
polypropylene tubes, capped and frozen at
-50'C until analysis. Free and total testos-
terone were determined by commercial
RIA Coat-A-Count method (Diagnostic
Products Corporation, Los Angeles, CA).
Each sample was analyzed in duplicate.
Strength values were determined at a
local gym. Strength scores were determined
by the one repetition maximum (1 RM) in
the bench press and back squat.
A microwave digestion technique was
developed for sample digestion prior to
plasma boron analysis (11). The microwave
digestion system (CEM Corp., Matthews,
NC) was equipped with a 600-W mag-
netron power source that is adjustable in
1% increments. The system included a
rotating turntable, a fluoropolymer casted
heating chamber, and high-volume exhaust
blower. Time and power source were con-
trolled by a programable microprocessor.
Digestion was carried out in 120-ml Teflon
PFA vessels with relief valves. The Teflon
PFA vessels were sealed, using a capping
station, to 12 ft lb torque for proper valve
operation.
Acids used for digestion and ICP rinse
solution were double-distilled from vycor
ultrapure nitric (15.8 N) or hydrochloric
(6 M). Water used for rinse and dilution
was deionized and tripled-filtered, 17.8
MQ/cm, and boron content below detec-
tion limit.
For blood digestion, the digestion vessels
were weighed to four decimal places and
approximately 4 ml (g) of plasma sample
was transferred directly to the vessel by
Eppendorf pipette with metal-free dispos-
able tips. Two ml ofconcentrated (15.8 N)
nitric acid was then added to the vessel.
The safety valve and cap were placed on
the vessel and tightened using the capping
station. Vessels were placed into the rotat-
ing turntable ofthe microwave.
Four cycles of digestion in the
microwave were required. The first cycle
was programed for 4 min at 75% power,
followed by 8 min at 50% power, and
finally 5 min at 0% power for cooling.
Cycles 2 to 4 entailed 4 min at 100%
power, followed by 8 min at 50% power,
and finally 5 min at 0% power for cooling.
The four cycles were required to insure the
complete digestion ofanalyte to a clear yel-
lowish fluid. Vessels were vented after each
cycle to prevent "blowing" of the pressure
reliefdisc and the concomitant sample loss.
Following the fourth digestion cycle, the
vessels were removed, vented and allowed
to cool to room temperature for 30 min,
and then opened before weighing. The dif-
ference between total-vessel weight and
digestion-vessel weight was used to adjust
the total weight of the solution. This pro-
cedure minimized sources of contamina-
tion. Digested samples were transferred
directly to acid-washed polypropylene
syringes and micron filtered directly into
the ICP autosampler.
Boron content of samples was deter-
mined with a Plasma II Inductively
Coupled Plasma Emission Spectrometer
(ICP). Prior to analysis, an optimization
was accomplished [using a 1 ppm (pg/ml)
boron standard as described previously
(11)] for power setting, nebulizer flow rate,
and viewing height above plasma.
The Plasma II ICP was allowed to
achieve a stable plasma by operating for
1 hr prior to analysis. Because ofthe tenac-
ity of boron and the high acid content of
the plasma samples, all nebulizer and peri-
staltic tubing was replaced every 8 hr. A
new quartz autosampler probe was installed
prior to the boron analysis.
Rinse solution was placed in a plastic
nitric acid-wash beaker. Solution height in
the rinse beaker was maintained above
sample height to alleviate sample-to-sample
contamination.
The limit of detection was determined
according to the test method of the U.S.
Environmental Protection Agency. Seven
consecutive measurements were obtained
on a 0.05 pg/ml boron standard. A detec-
tion limit of 12 ng/ml was determined by
multiplying the standard deviation ofthese
seven measurements by 3.
All analyses were conducted utilizing
boron-spiked acid blanks as control values.
No reference materials are certified for
boron concentration. National Institute of
Science and Technology Standard
Reference Material (NIST SRM) 1572, cit-
rus leaves, was used as a test material to
develop and validate the digestion proce-
dure, because it had been used by others
for boron analysis and allowed comparison
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Table 2. Boron in plasma and serum (ng/ml).
Plasma Serum
borona boronb
Median 25 22.3
Lowerquartile 16 18.3
Upperquartile 33 24.6
Minimum 14 8.3
Maximum 39 48.1
aMicrowave digestion and ICP analysis used in current
study, n = 12. bWet digestion and ICP-MS analysis, n=
50(7).
ofvalues. NIST SRM 1567a, wheat flour,
was selected as a second test material
because it contains a lower boron content
close to blood values. Standards of 1.0
pg/ml ofboron were analyzed with citrus
leaves and wheat flour SRM.
In the analysis of plasma boron, pool
control plasma was spiked with 0.5 pg/iml
inorganic boron. All blanks were spiked
with 0.5 and 0.05 pg/ml boron and ana-
lyzed with each plasma analysis. Also, an
unspiked sample ofthe pooled plasma was
analyzed with each run to check run-to-
run precision.
Results
Citrus leafand wheat flour digestate was a
clear reddish-brown color. Four samples of
SRM 1572, citrus leaves, were analyzed on
two separate occasions. Citrus leaf boron
values ranged from 49.3 to 54.9 pg/ml,
with a mean of51.8 ± 2.53 pg/iml (mean +
SD) and a CV of 4.9%. The mean
obtained for the citrus leaves with the pre-
sent method, 52 pg/ml, compares well
with the value obtained by Hunt and
Shuler (12), 50 pg/ml, and Clarke et al.
(6), 63 pg/mI.
Analysis offour samples ofSRM 1567a,
wheat flour, resulted in range of 0.31 to
0.55 pg/mI, with a mean of 0.45 ± 0.10
pg/ml. The mean obtained with the pre-
sent method, 0.45 pg/ml, compares favor-
ably with the value reported by Clarke et
al. (6), 0.58 pg/mi.
Ten boron tablets were analyzed on five
separate occasions, while six placebo tablets
were analyzed on three separate occasions
for boron content. The boron supplement
contained 2.49 ± 0.12 mg of boron and
the placebo 0.002 ± 0.001 mg. The boron
supplement was marketed to contain 5 mg
ofboron.
The digestion of plasma samples pro-
duced a clear yellow digestate. A pool
plasma was analyzed with each plasma
determination to check precision.
Analysis of control plasma spiked with
0.50 pg/ml level resulted in values rang-
ing from 0.51 to 0.61 pg/ml, with a
Table 3. Summary of subject group anthropometric
and dietary data.
Experimental Control
(n= 10) (n=9)
Age, years 23.2 ± 3.3 23.8 ± 2.9
Height, cm 174.7 ± 4.8 178.9 +6.6
Weight, kg 77.2 ± 9.5 82.2 +7.5
Training, years 7.3 4.7a 4.1 ±2.1
Dietb
Kcal/day 3556 ±2013a 3804±1063
% CHO 59.8 ± 14.6a 48.5 ±9.8
% PR0 18.3 ±7.5 19.4 ±7.9
% Fat 19.8 ±8.6 22.4± 11.4
Values are means ± SD.
aSignificant difference between groups (p<.05).
bAverage of day 1 to 3 of study period. Dietary values
from day47 to 49 did notdiffersignificantly.
mean of 0.56 ± 0.08 pg/ml and a CV of
13.7%. The mean recovery was 1 0%.
Blank spikes of 50 ng/ml resulted in a
92.7% and 98% recovery, this indicates
minimal volatilization of boron by these
procedures.
Six determinations ofthe pooled plasma
on different days ranged from 16 to 26
ng/ml with an average of 22 ng/ml. Of
the 19 subjects tested, 12 had detectable
concentrations of boron ranging from 14
ng/ml to 39 ng/ml, with a median of 25
ng/ml. Table 2 shows a comparison of
these values to serum values reported by
Abou-Shakra et al. (7).
Subjects
Group means of subjects' age, height,
weight and training experience are listed
with dietary data in Table 3. There was a
significant difference in training history
(p<0.05). The experimental group had
been weight training for 7.3 ± 4.7 (mean ±
SD) years, while the control group had 4.1
± 2.1 years of weight training experience.
Analysis of 3 days of dietary records
revealed that individual dietary habits and
group means did not deviate significantly
from pretest to posttest. However, total
kcal and carbohydrate intakes were signifi-
cantly (p<0.05) different between groups
(t-test) with the control group consuming
more total calories (3804 ± 1063 kcal ver-
sus 3556 ± 2013 kcal) but less carbohy-
drate (48.5 ± 9.8% vs 59.8 ± 14.6%) than
the experimental group.
Changes in the dependent variables are
consolidated in Table 4. ANOVA revealed
a significant increase (p<0.01) in lean
body mass (LBM) for all subjects as a
result of 7 weeks ofweight training; how-
ever, there was no significant difference
resulting from boron supplementation.
Body fat percentages decreased slightly in
both groups but the difference was not sta-
tistically significant.
Because ofinjuries, not all subjects were
able to perform posttest 1 RMs. Strength
values reported are for subjects who com-
pleted both the pre- and posttest squat or
bench press. In the squat, both the experi-
mental mean (n = 9) and the control group
mean (n = 6) increased from pretest to
posttest. This increase was significant
(p<0.001) in both groups and therefore
was probably the result of7 weeks oftrain-
ing (ANOVA). For the bench press, the
experimental group mean (n = 9) and the
control group mean (n = 9) increased from
pretest to posttest. This increase was again
significant (p<0.01) in both groups as a
result of 7 weeks of training (ANOVA).
There were no statistical differences in one
repetition maximum for the squat or the
bench press between groups as a result of
boron supplementation.
Total testosterone values for all subject
values were within the normal range of2.7
to 10.7 ng/ml. The experimental group's
mean total testosterone increased from
pretest to posttest, as did the control
group's. Total plasma testosterone was not
significantly different between groups as a
result of supplementation (ANOVA), but
significantly increased in both groups with
7 weeks oftraining (p<0.01).
Free testosterone values ranged from
5.44 to 34.67 pg/ml, which is within the
most reliable portions of the calibration
curve. One value was discarded in the
experimental group because of an inaccu-
rate assay value. Plasma-free testosterone
was not significantly different between
Table 4. Summary ofdependent variable changes.
Boron (n= 10) Control (n= 9)
Variable Pretest Posttest Pretest Posttest
Lean body mass, kg 70.2 ± 7.9 71.2 ± 7.3 d 72.4 ± 5.5 73.3 ± 5.1 d
Bodyfat, % 8.8 ± 1.8 8.3 ± 1.5 11.7 ±2.2 10.8 ±3.0
1 RM squat, kg a 151.2 ±32.5 159.6 ±31.4 e 136.5±36.8 146.6 ± 15.0 e
1 RM bench press, kgb 128.6 ± 22.4 130.5 ± 22.9 d 108.6 ± 24.7 114.1 ± 23.7
Total testo, ng/ml 5.4 ± 1.6 7.2 ± 2.7d 5.4± 2.1 6.5± 1.9 d
Free testo, pg/mI c 17.3 ± 8.5 19.9 ± 6.6 19.5 ± 7.3 20.86 ± 7.2
RM, repetition maximum. Values are means ± SD. aBoron n = 9; control n= 6. bBoron n = 9. CBoron n = 9. dp<D.D
vs pretest. ep<0.001 vs pretest.
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Table 5. Individual data for plasma boron (ng/ml).
Boron (n= 10) Control In=9)
Pretest Posttest Pretest Posttest
<12 a 12 30 <12
24 56 22 <12
29 36 <12 17
<12 77 <12 17
30 <12 27 <12
15 .12 39 <12
28 24 <12 <12
19 23 <12 <12
14 14 <12 <12
22 75
Three replicates for each sample were averaged.
aBelow detection limit, 12 ppb.
groups or as a result of training overtime
(ANOVA). A 2 x 2 correlation matrix
between percent change of each plasma
testosterone value and percent change of
each strength value revealed no significant
relationships.
Individual boron values for both groups
pre- and posttest are shown in Table 5.
The experimental group demonstrated a
90% compliance in their supplementation
as determined by supplement collection on
day 49 of the study. The mean plasma
boron concentration of the experimental
group increased while the control group
mean decreased. Plasma boron values were
significantly different on account of group
membership (p<0.01). Despite the oppo-
site changes in plasma boron values, there
was no statistically significant effect oftime
on boron values (ANOVA). Post hoc
analysis (Fisher Least Significant
Differences) revealed no significant differ-
ence as a result of supplementation, possi-
bly because of the large standard deviation
ofthe posttest experimental cell mean.
Discussion
The increase of approximately 1 kg of
LBM through 7 weeks ofweight training
found in the present study is consistent
with the literature. Resistance training will
typically increase LBM. A 1 kg increase in
LBM was noted after only 5 weeks (13)
and 10 weeks (14) of weight/strength
training in 8 and 26 males, respectively.
The absence of change in free testos-
terone is in agreement with the literature as
well (15,16). The increase in plasma
testosterone was evident in both groups in
this study, so it cannot be attributed to
boron supplementation. The subjects dis-
played a high level ofmotivation and train-
ing intensity; therefore, the testosterone
increase was probably the result of body-
building training. A significant increase
(p<0.05) in serum total testosterone was
noted in subjects of similar training status
after 8 weeks oftraining (17).
Despite the overall increases in both
group means of total testosterone and
strength parameters as a result of training,
there was no correlation between the
increase in muscle strength and plasma
testosterone values. Therefore, the increase
in strength parameters was most likely the
result of a concentrated bodybuilding
training program.
It is highly probable that boron supple-
mentation increases plasma boron content.
A t-test ofpre- and posttest values of each
group revealed that plasma boron concen-
trations in the experimental group
increased significantly, while the control
group values decreased significantly
(p<0.05). The ANOVA approached signif-
icance (p<0.07) due to boron supplemen-
tation despite the large standard deviation
in the posttest experimental group values.
There was no significant correlation
between plasma boron and any dependent
variables. Furthermore, there was no con-
sistent trend between changes in plasma
boron and changes in testosterone or
strength values. For example, certain sub-
jects with a significant increase in plasma
boron demonstrated marginal increases in
total testosterone and strength, whereas
others with a significant decrease in plasma
boron demonstrated increases in total
testosterone and strength.
There was a wide variation in plasma
boron in the experimental group (.12
ng/ml to 77 ng/ml). Plasma boron values
may have fluctuated because ofthe timing
of supplement ingestion prior to blood
sampling. Subjects were instructed to take
one (2.5 mg) tablet per day; but were not
instructed to do so at a specific time ofthe
day. Five subjects displayed plasma boron
increases, while three displayed little or no
change in plasma boron (Table 5). Because
compliance was >90% in the experimental
group, and the experimental group dis-
played a significant increase in plasma
boron, it can be concluded that 7 weeks of
supplementation is capable of elevating
plasma boron.
It is noteworthy that seven members of
the control group had plasma boron values
at or below the detection limit; only five
had pretest values below detection limits.
The decline in posttest control values may
be the result of one or more factors.
Inductively coupled plasma emission spec-
trometer analysis near the detection limit
often resulted in negative values. Each
plasma sample was evaluated by three sepa-
rate readings and a negative value was aver-
aged with the remainingvalues as a "zero."
Another factor affecting plasma boron
may have been a fluctuation in boron
intake. A national data base for boron in
foods and personal care products has not
been established; therefore, it is not possi-
ble to quantify boron intake.
Also, plasma boron may have declined
because oftraining. Although subjects were
asked not to change their training regimens
for this study, it is not certain whether
their increased training intensity during
the study contributed to the decrease in
posttest plasma boron values. Though not
employed in the present study, a crossover
design would have further clarified the
influence oftraining on plasma boron.
The proposed efficacy of boron as an
ergogenic aid is based on its ability to
increase testosterone. Nielsen et al. (8)
proposed that the increase in serum
testosterone and P-estradiol demonstrated
in 12 postmenopausal women was the
result of an endocrine mechanism.
However, boron supplementation did not
increase plasma testosterone in young
males in the present study.
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